Amanote Research
Register
Sign In
ERCC1 Expression as a Predictive Marker of Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Concurrent Chemoradiation
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6604464
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2008
Authors
H J Jun
M J Ahn
H S Kim
S Y Yi
J Han
S K Lee
Y C Ahn
H-S Jeong
Y-I Son
J-H Baek
K Park
Publisher
Springer Science and Business Media LLC
Related search
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated With Cisplatin- Or Docetaxel-Based Chemotherapy/Chemoradiotherapy
PLoS ONE
Multidisciplinary
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Concurrent Chemoradiation in Head and Neck Cancers With Weekly Cisplatin: Analysing Toxicities
International Journal of Research in Medical Sciences
Post-Operative Concurrent Chemoradiation for Patients With Non-Squamous Cell Carcinoma of Head and Neck: A Retrospective Cohort of the Uncommon Cancers
Asian Pacific Journal of Cancer Prevention
The Prognostic and Predictive Value of Excision Repair Cross-Complementation Group 1 (ERCC1) Protein in 1288 Patients With Head and Neck Squamous Cell Carcinoma Treated With Platinum-Based Therapy: A Meta-Analysis
European Archives of Oto-Rhino-Laryngology
Medicine
Otorhinolaryngology
Radical Radiotherapy With Concurrent Weekly Cisplatin in Loco-Regionally Advanced Squamous Cell Carcinoma of the Head and Neck- A Single Institution Experience
Journal of Evolution of Medical and Dental Sciences
Synergistic Antitumor Effect of AAV-mediated TRAIL Expression Combined With Cisplatin on Head and Neck Squamous Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
ERCC1 mRNA Levels Can Predict the Response to Cisplatin-Based Concurrent Chemoradiotherapy of Locally Advanced Cervical Squamous Cell Carcinoma
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
